1 - 25 of 46 results for author:"Shim J.-H." in Literature citations
Results Customize
› Repeat search in UniProtKB (9)
| AMP-activated protein kinase-alpha1 as an activating kinase of TGF-beta-activated kinase 1 has a key role in inflammatory signals. Kim S.Y., Jeong S., Jung E., Baik K.H., Chang M.H., Kim S.A., Shim J.H., Chun E., Lee K.Y. Cell Death Dis 3:e357-e357(2012) · Mapped (2) |
| Enrichment and characterization of human dermal stem/progenitor cells using collagen type IV. Shim J.H., Kang H.H., Lee T.R., Shin D.W. J. Dermatol. Sci. 67:202-205(2012) · Mapped (5) |
| Control of bone resorption in mice by Schnurri-3. Wein M.N., Jones D.C., Shim J.H., Aliprantis A.O., Sulyanto R., Lazarevic V., Poliachik S.L., Gross T.S., Glimcher L.H. Proc. Natl. Acad. Sci. U.S.A. 109:8173-8178(2012) · Mapped (6) |
| Relationship of HLA-DRB1 alleles with hepatocellular carcinoma development in chronic hepatitis B patients. Jin Y.J., Shim J.H., Chung Y.H., Kim J.A., Choi J.G., Park W.H., Lee D., Lee Y.S., Kim S.E., Kim S.H. et al. J. Clin. Gastroenterol. 46:420-426(2012) · Mapped (306) |
| The retinoic acid-induced up-regulation of insulin-like growth factor 1 and 2 is associated with prolidase-dependent collagen synthesis in UVA-irradiated human dermal equivalents. Shim J.H., Shin D.W., Lee T.R., Kang H.H., Jin S.H., Noh M. J. Dermatol. Sci. 66:51-59(2012) · Mapped (12) |
| Reciprocal inhibition between the transforming growth factor-beta-activated kinase 1 (TAK1) and apoptosis signal-regulating kinase 1 (ASK1) mitogen-activated protein kinase kinase kinases and its suppression by TAK1-binding protein 2 (TAB2), an adapter protein for TAK1. Kim S.Y., Shim J.H., Chun E., Lee K.Y. J. Biol. Chem. 287:3381-3391(2012) · Mapped (17) |
| HLA-DRB1*010101 allele is closely associated with poor virological response to lamivudine therapy in patients with chronic hepatitis B. Jin Y.J., Shim J.H., Chung Y.H., Kim J.A., Choi J.G., Park W.H., Lee D., Kim S.E., Lee Y.S., Kim S.H. et al. Digestion 84 Suppl 1:35-42(2011) · Mapped (306) |
| Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome-like skeletal defects induced by Pdk1 or Cbp mutations in mice. Shim J.H., Greenblatt M.B., Singh A., Brady N., Hu D., Drapp R., Ogawa W., Kasuga M., Noda T., Yang S.H. et al. J. Clin. Invest. 122:91-106(2012) · Mapped (32) |
| Single nucleotide polymorphisms associated with metastatic tumour antigen 1 overexpression in patients with hepatocellular carcinoma. Lee S.H., Chung Y.H., Kim J.A., Lee D., Jin Y.J., Shim J.H., Jang M.K., Cho E.Y., Shin E.S., Lee J.E. et al. Liver Int. 32:457-466(2012) · Mapped (13) |
| MLK3 regulates bone development downstream of the faciogenital dysplasia protein FGD1 in mice. Zou W., Greenblatt M.B., Shim J.H., Kant S., Zhai B., Lotinun S., Brady N., Hu D.Z., Gygi S.P., Baron R. et al. J. Clin. Invest. 121:4383-4392(2011) · Mapped (1) |
| Involvement of progranulin in the enhancement of hippocampal neurogenesis by voluntary exercise. Asakura R., Matsuwaki T., Shim J.H., Yamanouchi K., Nishihara M. Neuroreport 22:881-886(2011) · Mapped (15) |
| Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1. Urusova D.V., Shim J.H., Kim D.J., Jung S.K., Zykova T.A., Carper A., Bode A.M., Dong Z. Cancer Prev Res (Phila) 4:1366-1377(2011) · Mapped (4) |
| Noninvasive diagnostic criteria for hepatocellular carcinoma in hepatic masses >2 cm in a hepatitis B virus-endemic area. Kim S.E., Lee H.C., Shim J.H., Park H.J., Kim K.M., Kim P.N., Shin Y.M., Yu E.S., Chung Y.H., Suh D.J. Liver Int. 31:1468-1476(2011) · Mapped (3) |
| The antioxidant Trolox helps recovery from the familial Parkinson's disease-specific mitochondrial deficits caused by PINK1- and DJ-1-deficiency in dopaminergic neuronal cells. Shim J.H., Yoon S.H., Kim K.H., Han J.Y., Ha J.Y., Hyun D.H., Paek S.H., Kang U.J., Zhuang X., Son J.H. Mitochondrion 11:707-715(2011) · Mapped (12) |
| PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells. Lee K.Y., Lee J.W., Nam H.J., Shim J.H., Song Y., Kang K.W. Mol. Cells 32:107-111(2011) · Mapped (6) |
| IL-32gamma inhibits cancer cell growth through inactivation of NF-kappaB and STAT3 signals. Oh J.H., Cho M.C., Kim J.H., Lee S.Y., Kim H.J., Park E.S., Ban J.O., Kang J.W., Lee D.H., Shim J.H. et al. Oncogene 30:3345-3359(2011) · Mapped (14) |
| DJ-1 mediates paraquat-induced dopaminergic neuronal cell death. Kwon H.J., Heo J.Y., Shim J.H., Park J.H., Seo K.S., Ryu M.J., Han J.S., Shong M., Son J.H., Kweon G.R. Toxicol. Lett. 202:85-92(2011) · Mapped (2) |
| T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORgammat. Lazarevic V., Chen X., Shim J.H., Hwang E.S., Jang E., Bolm A.N., Oukka M., Kuchroo V.K., Glimcher L.H. Nat. Immunol. 12:96-104(2011) · Mapped (9) |
| The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. Greenblatt M.B., Shim J.H., Zou W., Sitara D., Schweitzer M., Hu D., Lotinun S., Sano Y., Baron R., Park J.M. et al. J. Clin. Invest. 120:2457-2473(2010) · Mapped (6) |
| Downregulation of immune response by the human cytokines Interleukin-32alpha and beta in cell-mediated rejection. Chae J.I., Shim J.H., Lee K.S., Cho Y.S., Lee K.S., Yoon d.o. Y., Kim S.H., Chung H.M., Koo D.B., Park C.S. et al. Cell. Immunol. 264:47-53(2010) · Mapped (5) |
| The prolyl isomerase Pin1 induces LC-3 expression and mediates tamoxifen resistance in breast cancer. Namgoong G.M., Khanal P., Cho H.G., Lim S.C., Oh Y.K., Kang B.S., Shim J.H., Shim J.H., Yoo J.C., Choi H.S. J. Biol. Chem. 285:23829-23841(2010) · Mapped (6) |
| Epigallocatechin gallate suppresses lung cancer cell growth through Ras-GTPase-activating protein SH3 domain-binding protein 1. Shim J.H., Su Z.Y., Chae J.I., Kim D.J., Zhu F., Ma W.Y., Bode A.M., Yang C.S., Dong Z. Cancer Prev Res (Phila) 3:670-679(2010) · Mapped (8) |
| TAK1 mediates BMP signaling in cartilage. Greenblatt M.B., Shim J.H., Glimcher L.H. Ann. N. Y. Acad. Sci. 1192:385-390(2010) · Mapped (4) |
| Structural diversity of the active N-terminal kinase domain of p90 ribosomal S6 kinase 2. Malakhova M., Kurinov I., Liu K., Zheng D., D'Angelo I., Shim J.H., Steinman V., Bode A.M., Dong Z. PLoS ONE 4:E8044-E8044(2009) · UniProtKB (1) |
| TAK1 is an essential regulator of BMP signalling in cartilage. Shim J.H., Greenblatt M.B., Xie M., Schneider M.D., Zou W., Zhai B., Gygi S., Glimcher L.H. EMBO J. 28:2028-2041(2009) · Mapped (45) |